UBE3A reinstatement as a disease‐modifying therapy for Angelman syndrome - Elgersma - 2021 - Developmental Medicine & Child Neurology - Wiley Online Library
An Autism-Linked Mutation Disables Phosphorylation Control of UBE3A: Cell
Frontiers | From UBE3A to Angelman syndrome: a substrate perspective
Ube3a-ATS - Wikipedia
CytoCell Angelman (UBE3A/D15S10) FISH Probe | OGT
UBE3A Gene - GeneCards | UBE3A Protein | UBE3A Antibody
Frontiers | The Autism and Angelman Syndrome Protein Ube3A/E6AP: The Gene, E3 Ligase Ubiquitination Targets and Neurobiological Functions
IVD UBE3A/PML - ISH Probes - Molecular Pathology
UBE3A Gene - GeneCards | UBE3A Protein | UBE3A Antibody
New UBE3A Gene Mutation Linked to Severe Angelman in Sisters in China
JCI - CRISPR/Cas9 directed to the Ube3a antisense transcript improves Angelman syndrome phenotype in mice
Welcome to The Visible Embryo
Frontiers | UBE3A and Its Link With Autism
UBE3A Gene | Understanding the Autism and The Brain Relationship
Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome | SpringerLink
What is Angelman Syndrome?
Frontiers | The Autism and Angelman Syndrome Protein Ube3A/E6AP: The Gene, E3 Ligase Ubiquitination Targets and Neurobiological Functions
Ube3a Imprinting Impairs Circadian Robustness in Angelman Syndrome Models - ScienceDirect
Cells | Free Full-Text | Generation and Characterization of a Novel Angelman Syndrome Mouse Model with a Full Deletion of the Ube3a Gene
Common genetic variation in the Angelman syndrome imprinting centre affects the imprinting of chromosome 15 | European Journal of Human Genetics
UBE3A-ATS is only expressed in neuron cultures and correlates with... | Download Scientific Diagram
